Literature DB >> 11823448

Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12.

Emilia Vitale1, Stuart Cook, Rong Sun, Claudia Specchia, Kavitha Subramanian, Mariano Rocchi, Douglas Nathanson, Marvin Schwalb, Marcella Devoto, Christine Rohowsky-Kochan.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a probable immune-mediated pathogenesis. Strong evidence supports the hypothesis that MS is determined by genetic and environmental factors, but these factors remain largely undefined. The genetic component is suggested by a higher concordance rate in monozygotic (28%) versus dizygotic (5%) twins as well as familial recurrence risk. Several studies have shown association of MS with the histocompatibility leukocyte antigen (HLA) class II region, specifically DR15, DQ6. However, there is no convincing evidence of a common susceptibility locus. We have identified a pedigree of Pennsylvania Dutch extraction, in which MS segregates with an autosomal dominant inheritance pattern. We have collected blood samples from 18 family members, seven of whom show typical signs of MS lesions by magnetic resonance imaging. The 18 individuals were serotyped for HLA class I and II and analyzed by a genome-wide screen for linkage analysis. We have found evidence for suggestive linkage to markers on 12p12 with a maximum multipoint LOD score of 2.71, conditional on the presence of DR15, DQ6. Contingency table analysis showed that all MS affected individuals have both the DR15, DQ6 allele and the 12p12 haplotype whereas the unaffected individuals have either one or neither of these markers (P = 0.00011). Our data suggests that both HLA DR15, DQ6 and a novel locus on chromosome 12p12 may be necessary for development of MS in this family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823448     DOI: 10.1093/hmg/11.3.295

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  The genetic aspects of multiple sclerosis.

Authors:  Stephen Sawcer
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

2.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

3.  Dissection of a locus on mouse chromosome 5 reveals arthritis promoting and inhibitory genes.

Authors:  Therese Lindvall; Jenny Karlsson; Rikard Holmdahl; Asa Andersson
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

4.  A genome-wide scan in forty large pedigrees with multiple sclerosis.

Authors:  Cristen J Willer; David A Dyment; Stacey Cherny; Sreeram V Ramagopalan; Blanca M Herrera; Katie M E Morrison; A Dessa Sadovnick; Neil J Risch; George C Ebers
Journal:  J Hum Genet       Date:  2007-11-15       Impact factor: 3.172

5.  HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family.

Authors:  L Mosca; V Mantero; S Penco; L La Mantia; S De Benedetti; M R Marazzi; C Spreafico; C Erminio; L Grassi; G Lando; M Zagaria; E Agostoni; A Protti
Journal:  Funct Neurol       Date:  2017 Apr/Jun

6.  Autoimmune Disease Associated CLEC16A Variants Convey Risk of Parkinson's Disease in Han Chinese.

Authors:  Hui-Hui Fan; Lei Cui; Xiao-Xia Jiang; Ya-Dan Song; Shu-Shu Liu; Ke-Yun Wu; Hao-Jia Dong; Miao Mao; Begench Ovlyakulov; Hong-Mei Wu; Jian-Hong Zhu; Xiong Zhang
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

7.  Variants of ST8SIA1 are associated with risk of developing multiple sclerosis.

Authors:  Seema Husain; Cagri Yildirim-Toruner; Justin P Rubio; Judith Field; Marvin Schwalb; Stuart Cook; Marcella Devoto; Emilia Vitale
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.